BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31522411)

  • 1. Immunophenotyping by Mass Cytometry.
    Behbehani GK
    Methods Mol Biol; 2019; 2032():31-51. PubMed ID: 31522411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of Mass Cytometry in Clinical Medicine: The Promise and Perils of Clinical CyTOF.
    Behbehani GK
    Clin Lab Med; 2017 Dec; 37(4):945-964. PubMed ID: 29128078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlabeled Competitor Antibody to Reduce Nonlinear Signal Spillover in Mass Cytometry.
    Sekhri P; Kim MY; Behbehani GK
    Cytometry A; 2019 Aug; 95(8):898-909. PubMed ID: 31120628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent Cell Barcoding for Immunophenotyping.
    Giudice V; Fantoni G; Biancotto A
    Methods Mol Biol; 2019; 2032():53-68. PubMed ID: 31522412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Dimensional Immunophenotyping with Fluorescence-Based Cytometry: A Practical Guidebook.
    Mair F; Tyznik AJ
    Methods Mol Biol; 2019; 2032():1-29. PubMed ID: 31522410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum-conjugated antibodies for application in mass cytometry.
    Mei HE; Leipold MD; Maecker HT
    Cytometry A; 2016 Mar; 89(3):292-300. PubMed ID: 26355391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T-Cell Phenotyping Using CyTOF.
    Barcenilla H; Pihl M; Sjögren F; Magnusson L; Casas R
    Methods Mol Biol; 2023; 2559():231-242. PubMed ID: 36180636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of minimal residual disease.
    Deptala A; Mayer SP
    Methods Cell Biol; 2001; 64():385-420. PubMed ID: 11070849
    [No Abstract]   [Full Text] [Related]  

  • 9. Titration of Mass Cytometry Reagents.
    van Vreden C; Niewold P; McGuire HM; Fazekas de St Groth B
    Methods Mol Biol; 2019; 1989():83-92. PubMed ID: 31077100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytometry of Mass for Murine Immunoprofiling.
    Chandra V; McAllister F; Burks JK
    Methods Mol Biol; 2022; 2435():129-137. PubMed ID: 34993943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of Mass Cytometry Signal Background to Enable Optimal Core Panel Customization and Signal Threshold Gating.
    Au-Yeung A; Takahashi C; Mathews WR; O'Gorman WE
    Methods Mol Biol; 2019; 1989():35-45. PubMed ID: 31077097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scalable Conjugation and Characterization of Immunoglobulins with Stable Mass Isotope Reporters for Single-Cell Mass Cytometry Analysis.
    Hartmann FJ; Simonds EF; Vivanco N; Bruce T; Borges L; Nolan GP; Spitzer MH; Bendall SC
    Methods Mol Biol; 2019; 1989():55-81. PubMed ID: 31077099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad Immune Monitoring and Profiling of T Cell Subsets with Mass Cytometry.
    Brodie TM; Tosevski V
    Methods Mol Biol; 2018; 1745():67-82. PubMed ID: 29476463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotyping of Acute Lymphoblastic Leukemia.
    DiGiuseppe JA; Cardinali JL
    Methods Mol Biol; 2019; 2032():297-310. PubMed ID: 31522425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of multiparametric flow cytometry in the detection of minimal residual disease in acute leukaemia.
    Lee D; Grigoriadis G; Westerman D
    Pathology; 2015 Dec; 47(7):609-21. PubMed ID: 26517623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry.
    Chevrier S; Crowell HL; Zanotelli VRT; Engler S; Robinson MD; Bodenmiller B
    Cell Syst; 2018 May; 6(5):612-620.e5. PubMed ID: 29605184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method for Tagging Antibodies with Metals for Mass Cytometry Experiments.
    Chang SG; Guidos CJ
    Methods Mol Biol; 2019; 1989():47-54. PubMed ID: 31077098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal residual disease testing of acute leukemia by flow cytometry immunophenotyping: a retrospective comparison of detection rates with flow cytometry DNA ploidy or FISH-based methods.
    Zwick D; Cooley L; Hetherington M
    Lab Hematol; 2006; 12(2):75-81. PubMed ID: 16751134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotyping of tumor infiltrating immune cells using mass-cytometry (CyTOF).
    Maby P; Corneau A; Galon J
    Methods Enzymol; 2020; 632():339-368. PubMed ID: 32000904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of T-Cell Diversity Using Mass Cytometry.
    O'Boyle KC; Ohtani T; Manne S; Bengsch B; Henrickson SE; Wherry EJ; Alanio C
    Methods Mol Biol; 2020; 2111():1-20. PubMed ID: 31933194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.